Literature DB >> 19528252

Regulatory role of tyrosine phosphorylation in the swelling-activated chloride current in isolated rabbit articular chondrocytes.

Noriaki Okumura1, Shinji Imai, Futoshi Toyoda, Eiji Isoya, Kousuke Kumagai, Hiroshi Matsuura, Yoshitaka Matsusue.   

Abstract

Articular chondrocytes are exposed in vivo to the continually changing osmotic environment and thus require volume regulatory mechanisms. The present study was designed to investigate (i) the functional role of the swelling-activated Cl(-) current (I(Cl,swell)) in the regulatory volume decrease (RVD) and (ii) the regulatory role of tyrosine phosphorylation in I(Cl,swell), in isolated rabbit articular chondrocytes. Whole-cell membrane currents were recorded from chondrocytes in isosmotic, hyposmotic and hyperosmotic external solutions under conditions where Na(+), K(+) and Ca(2+) currents were minimized. The cell surface area was also measured using microscope images from a separate set of chondrocytes and was used as an index of cell volume. The isolated chondrocytes exhibited a RVD during sustained exposure to hyposmotic solution, which was mostly inhibited by the I(Cl,swell) blocker 4-(2-butyl-6,7-dichloro-2-cyclopentyl-indan-1-on-5-yl)oxobutyric acid (DCPIB) at 20 microM. Exposure to a hyposmotic solution activated I(Cl,swell), which was also largely inhibited by 20 microM DCPIB. I(Cl,swell) in rabbit articular chondrocytes had a relative taurine permeability (P(tau)/P(Cl)) of 0.21. Activation of I(Cl,swell) was significantly reduced by the protein tyrosine kinase (PTK) inhibitor genistein (30 microM) but was only weakly affected by its inactive analogue daidzein (30 microM). Intracellular application of protein tyrosine phosphatase (PTP) inhibitor sodium orthovanadate (250 and 500 microM) resulted in a gradual activation of a Cl(-) current even in isosmotic solutions. This Cl(-) current was almost completely inhibited by 4,4-diisothiocyanatostilbene-2,2-disulfonate (DIDS, 500 microM) and was also largely suppressed by exposure to hyperosmotic solution, thus indicating a close similarity to I(Cl,swell). Pretreatment of chondrocytes with genistein significantly prevented the activation of the Cl(-) current by sodium orthovanadate, suggesting that the basal activity of endogenous PTK is required for the activation of this Cl(-) current. Our results provide evidence to indicate that activation of I(Cl,swell) is involved in RVD in isolated rabbit articular chondrocytes and is facilitated by tyrosine phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19528252      PMCID: PMC2746609          DOI: 10.1113/jphysiol.2009.174177

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  61 in total

Review 1.  Intracellular signalling involved in volume regulatory decrease.

Authors:  E K Hoffmann
Journal:  Cell Physiol Biochem       Date:  2000

Review 2.  Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD).

Authors:  Y Okada; E Maeno; T Shimizu; K Dezaki; J Wang; S Morishima
Journal:  J Physiol       Date:  2001-04-01       Impact factor: 5.182

3.  Membrane stretch activates a potassium channel in pig articular chondrocytes.

Authors:  M Martina; J W Mozrzymas; F Vittur
Journal:  Biochim Biophys Acta       Date:  1997-10-23

4.  Regulatory volume decrease (RVD) by isolated and in situ bovine articular chondrocytes.

Authors:  P G Bush; A C Hall
Journal:  J Cell Physiol       Date:  2001-06       Impact factor: 6.384

5.  Agents that increase tyrosine phosphorylation activate a non-selective cation current in single rabbit portal vein smooth muscle cells.

Authors:  A P Albert; A S Aromolaran; W A Large
Journal:  J Physiol       Date:  2001-01-15       Impact factor: 5.182

6.  Regulation of I(Cl,swell) in neuroblastoma cells by G protein signaling pathways.

Authors:  A Y Estevez; T Bond; K Strange
Journal:  Am J Physiol Cell Physiol       Date:  2001-07       Impact factor: 4.249

7.  Tyrosine kinase activation is an immediate and essential step in hypotonic cell swelling-induced ERK activation and c-fos gene expression in cardiac myocytes.

Authors:  J Sadoshima; Z Qiu; J P Morgan; S Izumo
Journal:  EMBO J       Date:  1996-10-15       Impact factor: 11.598

8.  Volume-regulated chloride conductance in the LNCaP human prostate cancer cell line.

Authors:  Y M Shuba; N Prevarskaya; L Lemonnier; F Van Coppenolle; P G Kostyuk; B Mauroy; R Skryma
Journal:  Am J Physiol Cell Physiol       Date:  2000-10       Impact factor: 4.249

9.  Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes.

Authors:  Y Geng; J Valbracht; M Lotz
Journal:  J Clin Invest       Date:  1996-11-15       Impact factor: 14.808

10.  Characterization of volume-sensitive taurine- and Cl(-)-permeable channels.

Authors:  L J Galietta; S Falzoni; F Di Virgilio; G Romeo; O Zegarra-Moran
Journal:  Am J Physiol       Date:  1997-07
View more
  9 in total

1.  17β-Oestradiol inhibits doxorubicin-induced apoptosis via block of the volume-sensitive Cl(-) current in rabbit articular chondrocytes.

Authors:  Kousuke Kumagai; Shinji Imai; Futoshi Toyoda; Noriaki Okumura; Eiji Isoya; Hiroshi Matsuura; Yoshitaka Matsusue
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

2.  P2X7 ionotropic receptor is functionally expressed in rabbit articular chondrocytes and mediates extracellular ATP cytotoxicity.

Authors:  Hitoshi Tanigawa; Futoshi Toyoda; Kosuke Kumagai; Noriaki Okumura; Tsutomu Maeda; Hiroshi Matsuura; Shinji Imai
Journal:  Purinergic Signal       Date:  2018-05-29       Impact factor: 3.765

3.  Effects of diadenosine tetraphosphate on FGF9-induced chloride flux changes in achondroplastic chondrocytes.

Authors:  Fernando Huete; Ana Guzman-Aranguez; Javier Ortín; Charles H V Hoyle; Jesús Pintor
Journal:  Purinergic Signal       Date:  2011-05-11       Impact factor: 3.765

Review 4.  K+ and Ca2+ Channels Regulate Ca2+ Signaling in Chondrocytes: An Illustrated Review.

Authors:  Yoshiaki Suzuki; Hisao Yamamura; Yuji Imaizumi; Robert B Clark; Wayne R Giles
Journal:  Cells       Date:  2020-06-29       Impact factor: 6.600

5.  Biochemical similarity between cultured chondrocytes and in situ chondrocytes by chemometric analysis from FTIR microspectroscopy.

Authors:  Monica Maribel Mata-Miranda; Adriana Martinez-Cuazitl; Carla Ivonne Guerrero-Robles; Jesus Emmanuel Noriega-Gonzalez; Juan Salvador Garcia-Hernandez; Gustavo Jesus Vazquez-Zapien
Journal:  Biotechnol Rep (Amst)       Date:  2019-11-09

Review 6.  Cell Death Induction and Protection by Activation of Ubiquitously Expressed Anion/Cation Channels. Part 1: Roles of VSOR/VRAC in Cell Volume Regulation, Release of Double-Edged Signals and Apoptotic/Necrotic Cell Death.

Authors:  Yasunobu Okada; Ravshan Z Sabirov; Kaori Sato-Numata; Tomohiro Numata
Journal:  Front Cell Dev Biol       Date:  2021-01-12

7.  Mechanosensory and mechanotransductive processes mediated by ion channels in articular chondrocytes: Potential therapeutic targets for osteoarthritis.

Authors:  Kun Zhang; Lifu Wang; Zhongcheng Liu; Bin Geng; Yuanjun Teng; Xuening Liu; Qiong Yi; Dechen Yu; Xiangyi Chen; Dacheng Zhao; Yayi Xia
Journal:  Channels (Austin)       Date:  2021-12       Impact factor: 2.581

8.  The COX-2 selective blocker etodolac inhibits TNFα-induced apoptosis in isolated rabbit articular chondrocytes.

Authors:  Kousuke Kumagai; Mitsuhiko Kubo; Shinji Imai; Futoshi Toyoda; Tsutomu Maeda; Noriaki Okumura; Hiroshi Matsuura; Yoshitaka Matsusue
Journal:  Int J Mol Sci       Date:  2013-09-30       Impact factor: 5.923

9.  Activation of a chondrocyte volume-sensitive Cl(-) conductance prior to macroscopic cartilage lesion formation in the rabbit knee anterior cruciate ligament transection osteoarthritis model.

Authors:  K Kumagai; F Toyoda; C A Staunton; T Maeda; N Okumura; H Matsuura; Y Matsusue; S Imai; R Barrett-Jolley
Journal:  Osteoarthritis Cartilage       Date:  2016-06-04       Impact factor: 6.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.